Please login to the form below

Not currently logged in
Email:
Password:

clinical trials

This page shows the latest clinical trials news and features for those working in and with pharma, biotech and healthcare.

Akcea steals march on Alnylam with NICE approval

Akcea steals march on Alnylam with NICE approval

This is vital for Tegsedi, which had generally been seen as the runner-up to Onpattro in terms of the data produced in their pivotal clinical trials.

Latest news

  • CAR-T player Autolus seeks $100m from follow-on financing CAR-T player Autolus seeks $100m from follow-on financing

    proceeds of around $94m and its existing cash mainly for trials of its lead candidates and to build up its manufacturing capacity. ... Part of the funding block will also go on completing the proof-of-concept phases of its phase 1/2 clinical trials of

  • Roche says ‘discovery proteomics’ is heading for clinical trials Roche says ‘discovery proteomics’ is heading for clinical trials

    Proteomics was one technology name-checked by outgoing FDA Commissioner Scott Gottlieb in a recent statement admonishing the pharma industry for not adopting innovative approaches to clinical trials. ... The approach could support the design of more

  • Sanofi exits R&D pact with Alnylam on rare disease Sanofi exits R&D pact with Alnylam on rare disease

    Alnylam is preparing that for clinical testing, and if Sanofi exercises its option it will be responsible for any future development and commercialisation, paying royalties to Alnylam if approved. ... The clinical hold was lifted a few weeks later however

  • Success for AZ, setback for Sanofi in type 1 diabetes Success for AZ, setback for Sanofi in type 1 diabetes

    Both AZ and Sanofi/Lexicon’s drugs have been shown in clinical trials to achieve a significant and clinically-meaningful reductions from baseline in average blood glucose levels compared to insulin ... agency is also concerned that DKA may be hard to

  • Novo uses voucher for speedy answer on oral semaglutide Novo uses voucher for speedy answer on oral semaglutide

    Novo's submission for oral semaglutide for the treatment of glycaemic control in adults with type 2 diabetes is based on the results from 10 Pioneer clinical trials, which included more ... The FDA, which will make a decision by September, will review

More from news
Approximately 159 fully matching, plus 1,570 partially matching documents found.

Latest Intelligence

More from intelligence
Approximately 11 fully matching, plus 151 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 61 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 16 fully matching, plus 77 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Oncosec

OncoSec is a clinical-stage biotechnology company focused on developing cytokine-based intratumoral immunotherapies to stimulate the body's immune system to target...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics